<DOC>
	<DOCNO>NCT01238159</DOCNO>
	<brief_summary>The purpose study evaluate efficacy concomitant chemoradiation follow MIDLE chemotherapy stage I/II extranodal NK/T cell lymphoma .</brief_summary>
	<brief_title>Concomitant Chemo-radiotherapy Followed MIDLE Chemotherapy Stage I/II Extranodal NK/T-cell Lymphoma</brief_title>
	<detailed_description>Concomitant chemo-radiotherapy : Radiation 36-44 Gy/18-22 fraction ( 2 Gy/fraction ) Weekly Cisplatin 30mg/m2 + N/S 100ml MIV 30min Tri-weekly L-asparaginase 4000 IU IV ( D1 , 3 , 5 ) Rest period : 3 week MIDLE chemotherapy : Repeated every 28 day 2 cycle D1 Methotrexate 3g/m2 + D5W 500ml MIV 6 hour D2-D3 Etoposide 100mg/m2 + D5W 500ml MIV 90mins D2-D3 Ifosfamide 1000mg/m2 + D5W 100ml MIV 1hr D2-D3 Mesna 300mg/m2 + D5W 100ml MIV 15mins ( -15min , 4hrs 8hrs ifosfamide , total 3 dos ) D1-D4 Dexamethasone 40mg/d PO IV D4 , 6 , 8 , 14 , 10 L-asparaginase 6000IU/m2 + D5W 500ml MIV 2hours</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , Extranodal NK-T-Cell</mesh_term>
	<criteria>patient require biopsyproven diagnosis nasal ENKTL least 18 year old Ann Arbor stage IE IIE measurable disease Eastern Cooperative Oncology Group ( ECOG ) performance status 02 life expectancy great 12 week adequate hematologic ( hemoglobin &gt; 9.0 g/dL , absolute neutrophil count &gt; 1,500/uL platelet &gt; 100,000/uL ) renal ( serum creatinine &lt; 1.5 mg/dL , creatinine clearance &gt; 50 mL/min ) hepatic ( total bilirubin &lt; 2 time upper limit normal aspartate transferase &lt; 3 time upper limit normal ) function Diagnosis ENKTL base presence histological feature immunophenotypes compatible ENKTL ( e.g. , cytoplasmic CD3+ , CD20 , CD56+ , positive cytotoxic molecule positive EBV situ hybridization ) . Informed consent prior concomitant malignant tumor coexist medical problem sufficient severity prevent full compliance study protocol . ENKTL nonnasal site skin gastrointestinal tract exclude even localize . Other subtypes nonHodgkin lymphoma ( NHL ) , include myeloid/NK cell precursor acute leukemia , blastic NK cell lymphoma/precursor NK cell lymphoblastic leukemia , aggressive NK cell leukemia , peripheral T cell lymphoma , unspecified , exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Natural killer cell</keyword>
	<keyword>T cell</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Radiation</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>